Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation.
OBJECTIVE
Intestinal transplantation is a feasible therapy for patients with short-bowel syndrome. However, cytomegalovirus (CMV) enteritis can cause complications. The aim of this study was to investigate the value of polymerase chain reaction (PCR)-based detection methods for CMV in the management of patients with small bowel transplants.


METHODS
Comparative evaluation of PCR with histopathology, shell-vial assay, and tube culture of intestinal biopsy specimens was used for the diagnosis of CMV enteritis in 21 patients.


RESULTS
Ten patients experienced 21 episodes of CMV enteritis, diagnosed by histopathology, virology, or both. PCR had a sensitivity and specificity of 96% and 69%, respectively, compared with traditional methods, whereas the positive and negative predictive values were 35% and 99%, respectively. Three+ and 4+ signals corresponded to a specificity of 91% and positive predictive value of 59%, respectively. CMV was detected by PCR a median of 11 days (range, 0-32) earlier than other methods and lasted a median of 40 days (range, 21-80) in the 13 episodes, which became PCR-negative and in those patients who developed asymptomatic infection. In 8 episodes, CMV by PCR never became negative and was associated with a relapse of disease confirmed by other methods.


CONCLUSIONS
PCR is a sensitive method for the early detection of CMV in intestinal biopsy specimens and can be used for preemptive therapy after intestinal transplantation.
Kusne
S
S
Department of Surgery, University of Pittsburgh, Pennsylvania, USA.
Mañez
R
R
Frye
B L
BL
St George
K
K
Abu-Elmagd
K
K
Tabasco-Menguillon
J
J
Fung
J J
JJ
Todo
S
S
Rinaldo
C
C
Ehrlich
G D
GD
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001769:Blood / Q000821:virology; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D004247:DNA / Q000235:genetics*; D004064:Digestive System / Q000821:virology; D004751:Enteritis / Q000188:drug therapy / Q000453:epidemiology / Q000821:virology*; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D007422:Intestines / Q000473:pathology / Q000637:transplantation*; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications
D000998:Antiviral Agents; D004247:DNA; D015774:Ganciclovir